Blood Transfusion in Cardiac Surgery is a Risk Factor for Increased Hospital Length of Stay in Adult Patients
RBC transfusion is an independent risk factor for increased LOS in patients undergoing cardiac surgery.
Intraoperative Cell Salvage is Associated with Reduced Postoperative Blood Loss and Transfusion Requirements in Cardiac Surgery: A Cohort Study
The use of cell salvage throughout the entire procedure reduces postoperative blood loss and allogeneic RBC transfusion.
Pharmacologic Methods to Reduce Postoperative Bleeding in Adult Cardiac Surgery. A Mini-review
Pharmacologic methods should be part of a multimodal blood conservation programs.
Storage Time of Red Blood Cell Concentrates and Adverse Outcomes after Cardiac Surgery: A Cohort Study
The objective of the study was to test the hypothesis that longer storage time of RBCs increases the risk of adverse outcome after cardiac surgery.
Use of Confidex to Control Perioperative Bleeding in Pediatric Heart Surgery: Prospective Cohort Study
A prospective cohort study was conducted to evaluate the effect of a commercially available prothrombin complex (Confidex) administered in cardiac surgery after weaning from cardiopulmonary bypass of infants with nonsurgical bleeding.
Vacuum Assist: Angel or Demon CON
Vacuum-assisted venous drainage (VAVD) to enhance venous return during cardiopulmonary bypass (CPB) was described as early as 1958 but was not widely used until the late 1990s.
Vacuum-Assisted Venous Drainage, Angel or Demon: PRO?
Vacuum-assisted venous drainage (VAVD) was proposed to optimize venous drainage during bypass through femoral venous cannulation.
Has the New USP Assay for Heparin Affected Dosage for Patients Undergoing Cardiopulmonary Bypass?
A retrospective study was conducted to determine the heparin dose administered and the corresponding effect on patients undergoing coronary artery bypass grafting surgery using cardiopulmonary bypass.
From Bloodless Surgery to Patient Blood Management
Patient blood management strategies can be applied at every stage of care to surgical and nonsurgical patients, and they generally fall under one of these three categories (the so-called pillars of blood management): optimizing hematopoiesis and appropriate management of anemia, minimizing bleeding and blood loss, and harnessing and optimizing physiological tolerance of anemia through employing all available modalities while treatment is initiated.
Blood Substitutes: Evolution from Non Carrying to Oxygen-and Gas-Carrying Fluids
The development of oxygen (O2)-carrying blood substitutes has evolved from the goal of replicating blood O2 transport properties to that of preserving microvascular and organ function, reducing the inherent or potential toxicity of the material used to carry O2, and treating pathologies initiated by anemia and hypoxia.
Fabrication of Small-Diameter Vascular Scaffolds by Heparin-Bonded P(LLA-CL) Composite Nanofibers to Improve Graft Patency
The poor patency rate following small-diameter vascular grafting remains a major hurdle for the widespread clinical application of artificial bloodvessels to date.
A Retrospective Comparison of Blood Transfusion Requirements During Cardiopulmonary Bypass with Two Different Small Adult Oxygenators
A low haematocrit during cardiopulmonary bypass (CPB) is associated with adverse outcomes and often results in homologous blood transfusions.